FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/02/040349 [Registered on: 16/02/2022] Trial Registered Prospectively
Last Modified On: 13/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Shigru Mool Churna in Management of kidney stone. 
Scientific Title of Study   Randomized Controlled Trial of Shigru Mool Churna in Management of Mutrashmari. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Roshani prabhakar Gajbhiye 
Designation  PG scholar 
Affiliation  Government Ayurved college Nagpur 
Address  Government Ayurved college Nagpur
Sakkardara square
Nagpur
MAHARASHTRA
440024
India 
Phone  9527141205  
Fax    
Email  gajbhiye214@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Subhash Raut 
Designation  Professor M. D. ( Shalyatantra)  
Affiliation  Government Ayurved college Nagpur 
Address  Government Ayurved college Nagpur
Government Ayurved college Nagpur
Nagpur
MAHARASHTRA
440024
India 
Phone  9422108928  
Fax    
Email  drsyraut@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Roshani prabhakar Gajbhiye 
Designation  PG scholar 
Affiliation  Government Ayurved college Nagpur 
Address  Government Ayurved college Nagpur
Sakkardara square
Nagpur
MAHARASHTRA
440024
India 
Phone  9527141205  
Fax    
Email  gajbhiye214@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurved hospital Nagpur 
 
Primary Sponsor  
Name  Roshani Gajbhiye 
Address  Government Ayurved college Nagpur 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Roshani Gajbhiye  Government Ayurved college and hospital Nagpur  Shalyatantra department, Government Ayurved college,sakkardara square Nagpur.
Nagpur
MAHARASHTRA 
9527141205

gajbhiye214@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N399||Disorder of urinary system, unspecified. Ayurveda Condition: Mutrashmari,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Shigrumul, Reference: Charaksamhita, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Normal water), Additional Information:
2Comparator ArmDrugClassical(1) Medicine Name: Gokshur churn, Reference: Charaksamhita, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -normal water), Additional Information:
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient of Age group 18-60 years.

2. Patients irrespective of gender, religion, economical, status education occupation.

3. Patient having calculi size up to 10mm in kidney, ureter and bladder.

and

4. Patients having suffering from Mutrashmari without any major illness.

5. Mutrashmari with

intervention.

no other consequences and reluctant for

6 Patient will be selected after base line investigation. 7. Co-operative patients. 
 
ExclusionCriteria 
Details  1. Patient having calcull of size more than 10mm.

2. Acute retention of urine.

3. Hydronephrosis.

4. Impaired renal function.

5. Patient having severe obstructive uropathy.

6. Patient requiring emergency surgery like obstructed urinary calculi.

7. Malignancy

8. Non co-operative patient. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the effect of Gokshur Churna in the management of Mutrashmari. To compare the efficacy of Shigru Mool Chuma and Gokshur Churna in management of Mutrashmari.  1 months
Size and symptoms are the parameters will be assist 
 
Secondary Outcome  
Outcome  TimePoints 
To provide alternate management principle to patient of Mutrashmari.

To study literature regarding drug and disease 
1 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   25/02/2022 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="1" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
TITAL  Randomized Controlled Trial of Shigru Mool Churna in Management of Mutrashmari. 
Research question
Whether Shigru Mool Churna is effective in management of Mutrashmari thn Gokshur churna ? 
NULL HYPOTHESIS : Shigrumul churna and Gokshur churna is equally effective in the management of Mutrashmari. 
Alternative Hypothesis [H1]:
Shigru Mool Churna is more effective than Gokshur churna in management of Mutrashimari. 
STANDARD OPERATING PROCEDURE GROUP A (TRIAL GROUP)

Patient will be selected from O.P.D. and I.P.D. for clinical trail of drug. At first visit of patient after screening, written consent will be taken.

observation will be recorded.

18

GROUP B (CONTROL

GROUP)

Gokshur churna

Drugs

evening before meal)

Oral

for 30days

GROUP A (TRIAL GROUP)

Shigru Mool Churna

evening before meal)

Oral

Drinking Water

Drinking water

for 30days

150 gm of Churna of Shigru Mool will be given. Patient advised to take 5gm with provided 5gm spoon at morning and evening before meal. After completion of 15 days next 150 gm power sachet with 5gm spoon will be provided.

A proforma for dairy drug consumtion diary will be provided to patient.

patient will advised to come every week so that continuity of treatment and

Patient will be advised diet regime as per instruction designed for particular study.
(CONTROL GROUP)

.

Patient will be selected from O.P.D. and 1.P.D. for clinical trail of drug

At first visit of patient after screening, written consent will be taken.

150 gm of Churna of Gokshur will be given. Patient advised to take 5gm with

provided 5gm spoon at morning and evening before meal. After completion of 15

days next 150 gm power sachet with 5gm spoon will be provided.

A proforma for dairy drug consumtion diary will be provided to patient.

The patient will advised to come after a week so that continuity of treatment and

observation will be recorded. Patient will be advised diet regime as per instruction designed for particular study.

DISCUSSION:- Data obtained assessment will be analyzed and will be decided in final dissertation. 
CONCLUTION 
On the basis of available literature, observation and discussion will be precisely drawn and whole dissertation will be summarized . 











4)HYPOTHESIS

Churna?

 
Close